Evidence map›Paper›PMID 30049981›Full record

ArticleMolecules (Basel, Switzerland)2018

Design and Synthesis of New Benzophenone Derivatives with In Vivo Anti-Inflammatory Activity through Dual Inhibition of Edema and Neutrophil Recruitment.

Jaqueline P Januario, Thiago B de Souza, Stefânia N Lavorato, Tatiane C S Maiolini, Olívia S Domingos, João L Baldim, Laís R S Folquitto, Marisi G Soares, Daniela A Chagas-Paula, Danielle F Dias and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 15 citations in OpenAlex.

  1. The journal of venomous animals and toxins including tropical diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jaqueline P JanuarioChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. jaquelinepj@yahoo.com.br.
Thiago B de SouzaDepartment of Industrial Pharmacy, Federal University of Santa Maria, UFSM, Santa Maria 97105-900, Rio Grande do Sul, Brazil. thiagobs83@yahoo.com.br.
Stefânia N LavoratoCenter of Biological Sciences and Health, Federal University of Western Bahia, UFOB, Barreiras 47808-021, Bahia, Brazil. stelavorato@gmail.com.
Tatiane C S MaioliniChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. tatychryss@gmail.com.
Olívia S DomingosChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. oliviadomingos@hotmail.com.ORCID 0000-0003-3371-5777
João L BaldimChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. jotaelebaldim@gmail.com.
Laís R S FolquittoChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. lais.folquitto@gmail.com.
Marisi G SoaresChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. marisigs@gmail.com.
Daniela A Chagas-PaulaChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. daniapchpa@gmail.com.ORCID 0000-0003-2274-4919
Danielle F DiasChemistry Institute, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, Minas Gerais, Brazil. daniferdias@gmail.com.ORCID 0000-0001-9129-4734
Marcelo H Dos SantosDepartment of Chemistry, Federal University of Viçosa, UFV, Viçosa 36570-900, Minas Gerais, Brazil. marcelo_hs@yahoo.com.br.
Universidade Federal de Alfenas · BRUniversidade Federal de Santa Maria · BRUniversidade Federal de Viçosa · BRUniversidade Federal do Oeste da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel benzophenone derivatives containing a thiazole heterocyclic nucleus were designed by molecular hybridization. Molecular docking studies have demonstrated the inhibitory potential of the designed compounds against cyclooxygenase (COX) isoenzymes. These compounds were synthesized, characterized, and evaluated for their anti-inflammatory properties by the croton oil-induced ear edema assay to examine their effect on both prostaglandin (PG) production and neutrophils recruitment. The thiazole derivatives displayed a potent effect in terms of reducing ear edema. The analysis suggested that the presence of 4-phenyl-2-hydrazinothiazole and the absence of C4'-OCH₃ on the benzophenone derivative structure are strongly related to the inhibition of PG production. In addition, the derivatives

Indexed as

Drug DesignAnimalsAnti-Inflammatory AgentsBenzophenonesBinding SitesCatalytic DomainCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDisease Models, AnimalEdemaIsomerismMiceMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureAnti-Inflammatory AgentsbenzophenoneBenzophenonesCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase Inhibitorsear edemahydrazinothiazolemolecular dockingstructure activity relationshiptiosemicarbazone

Identifiers

PMID30049981
PMCPMC6222881
OpenAlexW2884264260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.